Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · IEX Real-Time Price · USD
27.70
+0.75 (2.78%)
Jul 2, 2024, 4:30 PM EDT - Market closed

Sanara MedTech Revenue

Sanara MedTech had revenue of $68.00M in the twelve months ending March 31, 2024, with 26.98% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $18.54M with 19.42% year-over-year growth. In the year 2023, Sanara MedTech had annual revenue of $64.99M with 41.77% growth.

Revenue (ttm)
$68.00M
Revenue Growth
+26.98%
P/S Ratio
3.51
Revenue / Employee
$635,557
Employees
107
Market Cap
238.92M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202364.99M19.15M41.77%
Dec 31, 202245.84M21.70M89.87%
Dec 31, 202124.14M8.56M54.90%
Dec 31, 202015.59M3.82M32.47%
Dec 31, 201911.77M5.93M101.56%
Dec 31, 20185.84M-466.90K-7.41%
Dec 31, 20176.30M796.89K14.47%
Dec 31, 20165.51M2.14M63.33%
Dec 31, 20153.37M739.55K28.09%
Dec 31, 20142.63M906.25K52.49%
Dec 31, 20131.73M552.85K47.11%
Dec 31, 20121.17M-1.04M-46.89%
Dec 31, 20112.21M1.30M142.71%
Dec 31, 2010910.42K622.40K216.10%
Dec 31, 2009288.02K-2.16K-0.75%
Dec 31, 2008290.18K-340.32K-53.98%
Dec 31, 2007630.51K440.75K232.27%
Dec 31, 2006189.76K-21.41K-10.14%
Dec 31, 2005211.17K37.08K21.30%
Dec 31, 2004174.09K--
Dec 31, 20030--
Dec 31, 2002125.00K104.04K496.40%
Dec 31, 200120.96K16.37K356.72%
Dec 31, 20004.59K-2.25M-99.80%
Dec 31, 19992.25M-573.97K-20.32%
Dec 31, 19982.82M-1.01M-26.41%
Dec 31, 19973.84M851.08K28.49%
Dec 31, 19962.99M2.23M296.06%
Dec 31, 1995754.15K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna SA 1.06B
MultiPlan 959.44M
AngioDynamics 324.01M
Pulmonx 72.99M
Semler Scientific 65.88M
Mersana Therapeutics 38.30M
Adaptimmune Therapeutics 18.36M
Molecular Partners AG 7.64M
Revenue Rankings